 |
PDBsum entry 1u5c
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Oxidoreductase
|
PDB id
|
|
|
|
1u5c
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Mapping the binding site for gossypol-Like inhibitors of plasmodium falciparum lactate dehydrogenase.
|
 |
|
Authors
|
 |
R.Conners,
F.Schambach,
J.Read,
A.Cameron,
R.B.Sessions,
L.Vivas,
A.Easton,
S.L.Croft,
R.L.Brady.
|
 |
|
Ref.
|
 |
Mol Biochem Parasitol, 2005,
142,
137-148.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Gossypol is a di-sesquiterpene natural-product in the form of a functionalised
binaphthyl and is isolated from cotton plants. The compound has long been known
to exhibit anti-malarial and other biological activities. Previous studies have
indicated that compounds of this type target Plasmodium falciparum lactate
dehydrogenase (pfLDH), an essential enzyme for energy generation within the
parasite. In this study, we report that simple naphthalene-based compounds, the
core of the gossypol structure, exhibit weak inhibition of the parasite lactate
dehydrogenase. Crystal structures of the complexes formed by binding of these
naphthalene-based compounds to their target enzyme have been used to delineate
the molecular features likely to form the gossypol binding site. Two modes of
binding are observed: one overlapping the pyruvate but not the co-factor site,
the other bridging the binding sites for the co-factor nicontinamide group and
pyruvate substrate. This latter site encompasses molecular features unique to
Plasmodium forms of LDH and is likely to represent the mode of binding for
gossypol derivatives that show selectivity for the parasite enzymes. We also
report a substrate analogue that unexpectedly binds within the adenine pocket of
the co-factor groove. Although these core pharmacophore-like molecules only
exhibit low levels of inhibitory activity, these molecular snapshots provide a
rational basis for renewed structure-based development of naphthalene-based
compounds as anti-malarial agents.
|
 |
|
|
|
|
 |